Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

shared by hamelinclara on 15 Jan 13 - No Cached

But now the drugs in the headlines are generics. As the industry has grown and matured, it's faced greater scrutiny from regulatory agencies. Now it faces many of the same setbacks that plague their branded brethren.
...

Cancel
Lipitor, Plavix, Lexapro and Seroquel
...

Cancel
these same manufacturers are facing a patent cliff of their own
...

Cancel
...2 more annotations...
generics have been plagued by high-profile manufacturing and quality issues that have raised questions about the sector's safety and ultimate viability.
...

Cancel
The market is increasingly complex for generic manufacturers, and business-as-usual isn't going to cut it. In my next post, I'll describe another critical issue facing these drugmakers and their relationship with regulatory agencies: moving into the new space of biologics.
...

Cancel

1 - 1 of 1

Showing 20▼ items per page